iifl-logo

Parmax Pharma Ltd AGM

46
(-1.77%)
May 9, 2025|12:00:00 AM

Parmax Pharma CORPORATE ACTIONS

10/05/2024calendar-icon
10/05/2025calendar-icon
PurposeAGM DateAnnouncement Date
AGM30 Sep 202417 Sep 2024
AGM 30/09/2024 This is to inform you that the 30th Annual General Meeting of the PARMAX PHARMA LIMITED held today, 30th September, 2024 at 3.00 pm at the registered office of the company and the meeting concluded at 4.40 pm. (As per BSE Announcement dated on 30/09/2024) Pursuant to Regulation 44(3) of SEBI (LODR), 2015; we hereby enclose the voting results of 30th Annual General Meeting held on Monday, 30th September, 2024 at 3.00 PM and consolidated Scrutinizers report pursuant to Section 108 of the Companies Act 2013 and Rule 20(4)(xii) of the Companies (Management and Administration) Rules, 2014. Read less.. (As Per BSE Announcement Dated on 02.10.2024)

Parmax Pharma: Related News

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.